ADC Therapeutics SA (NYSE:ADCT)
| 23.01 Delayed Data As of 4:00pm ET |  0.00 / 0.00%Today’s Change | 20.01 Today|||52-Week Range 56.59 | -28.12% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 23.01 |
| Today’s open | 23.22 |
| Day’s range | 22.80 - 23.37 |
| Volume | 224,453 |
| Average volume (3 months) | 341,791 |
| Market cap | $1.7B |
Data as of 4:00pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -116.16% |
| Earnings growth (this year) | -22.40% |
| Earnings growth (next 5 years) | +6.72% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.08 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 24, 2021 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$246.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
